Skip to main content

Articles

Original Research
Infliximab Dosing Patterns in a Sample of Patients with Crohn’s Disease: Results from a Medical Chart Review
Stakeholder Perspective
Infliximab Dosing for Crohn’s Disease: Too Much of a Good Thing?
Read More
Practice Management
Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the Trend
Stakeholder Perspective
Chronic Obstructive Pulmonary Disease Remains a Growing Population Health Concern
Read More
Healthcare Exchanges
Read More
The Objectives of the ACA
Read More
Healthcare Spending
Read More
Financial Concerns Related to Medicare
Read More
The Value and Benefit of American Health & Drug Benefits
Read More
Perspectives
Harnessing the Power of Big Data in Healthcare
Read More
Original Research
Considering Patient Preferences When Selecting Anti–Tumor Necrosis Factor Therapeutic Options
Stakeholder Perspective
In a Fix on Addressing Alternatives
Read More
Dermatology
Rosacea: A Multifaceted Skin Disorder
Read More
Page 151 of 245
Results 1501 - 1510 of 2441